Outpatient parenteral antibiotic therapy and follow-up during the COVID-19 pandemic

JAAPA. 2021 Dec 1;34(12):1. doi: 10.1097/01.JAA.0000800608.04046.79.

Authors

Katharine Breaux¹, Parisa Kahn, Alison Robins, Huan Xu

Affiliation

¹ At Michael E. DeBakey VA Medical Center in Houston, Tex., Katharine Breaux is a physician assistant and HIV coordinator in the infectious diseases section, Parisa Kahn is a clinical pharmacist, and Alison Robins and Huan Xu are infectious disease staff attending physicians. The authors have disclosed no potential conflicts of interest, financial or otherwise.

PMID: 34813544
DOI: 10.1097/01.JAA.0000800608.04046.79

No abstract available

MeSH terms

Ambulatory Care
Anti-Bacterial Agents / therapeutic use
COVID-19*
Follow-Up Studies
Humans
Outpatients
Pandemics*
SARS-CoV-2

Substances

Anti-Bacterial Agents